Why Consider Switching from Tirzepatide to Semaglutide
Louis Aronne is a paid consultant and advisory board member for Eli Lilly and Company, the study sponsor and the manufacturer of orforglipron and tirzepatide.
[1] [2] Administered as a once-weekly subcutaneous injection, Ozempic works by enhancing insulin secretion in response to elevated blood glucose, suppressing glucagon release, and slowing gastric emptying
Suspected side effects should be reported through the MHRA Yellow Card scheme to support ongoing medication safety monitoring
Addressing weight gain from antipsychotics Professor Dan Siskind, a psychiatrist and lead researcher, explained that the 36-week trial demonstrated the efficacy of semaglutide in people with schizophrenia, a population often affected by weight gain as a side effect of antipsychotic medications
Researchers transitioning between the two should recalculate everything